查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
2022-2029 年肝转移药物全球市场规模调查和预测，按原发性癌症、类型、分销渠道、地区分析
市场调查报告书
商品编码
1251569

2022-2029 年肝转移药物全球市场规模调查和预测，按原发性癌症、类型、分销渠道、地区分析

Global Liver Metastases Treatment Market Size study & Forecast, by Type by Primary Cancer, by Distribution Channel and Regional Analysis, 2022-2029
出版日期: | 出版商: Bizwit Research & Consulting LLP | 英文 | 商品交期: 2-3个工作天内

价格

2021 年全球肝转移药物市场价值约为 12 亿美元，预计在 2022-2029 年预测期内将以超过 7.2% 的健康增长率增长。

肝转移是指原发肿瘤或癌症转移至肝臟。 肝转移不是从肝臟开始，而是从其他受影响的区域扩散。 已经扩散到肝臟的癌症会导致肝转移。 肝转移瘤的治疗是用来治癒肝转移瘤的方法。 转移到肝臟的典型癌症包括乳腺癌、结肠癌、食道癌和肺癌。 乳腺癌和结直肠癌病例数量的增加、政府对癌症治疗的支持和承诺的增加、研发的进步、目标疾病发病率的上升等都是推动市场增长的因素。

根据世界癌症研究基金会的数据，2020年全球乳腺癌患者人数约占12.5%，而肺癌患者人数约占12.2%。 2020年大肠癌新增病例190万，在所有癌症类型中排名第三，占所有病例的10.7%。 此外，世界卫生组织于 2023 年 2 月宣布了一项新的全球乳腺癌框架，以实现到 2040 年避免 250 万例乳腺癌死亡的目标。 乳腺癌和结直肠癌病例的增加、政府支持和举措的增加是推动市场增长的主要因素。 此外，研发的进步和目标疾病发病率的上升也是推动市场扩张的重要因素。 在预测期内，肝转移治疗的技术进步和医疗保健研发的增加正在创造巨大的市场机会。 然而，肝转移药物的高成本将阻碍整个 2022-2029 年预测期内的市场增长。

全球肝转移药物市场研究考虑的主要区域是亚太地区、北美、欧洲、拉丁美洲和世界其他地区。 由于先进的癌症治疗方案的可用性、政府对癌症的有利政策以及美国等国家肝转移的高患病率，北美在收入方面占据了市场主导地位。 例如，据说美国每年约有140,000例肝转移病例。 由于医疗成本上升、医疗设施便利以及缺乏有效筛查等因素，预计亚太地区在预测期内将以最高复合年增长率增长。

内容

第 1 章执行摘要

  • 市场概况
  • 2019-2029 年各细分市场的全球市场估计和预测
    • 肝转移药物市场，按地区划分，2019-2029 年
    • 肝转移药物市场，按类型，2019-2029
    • 肝转移药物市场，按原发性癌症分类，2019-2029 年
    • 肝转移药物市场，按分销渠道，2019-2029 年
  • 主要趋势
  • 调查方法
  • 调查先决条件

第2章全球肝转移药物市场的定义和范围

  • 调查目的
  • 市场定义和范围
    • 调查范围
    • 工业发展
  • 本次调查涵盖的年份
  • 货币兑换率

第三章全球肝转移药物市场动态

  • 肝转移药物市场影响分析（2019-2029）
    • 市场驱动因素
      • 乳腺癌和结直肠癌患者人数增加
      • 政府加大对癌症治疗的支持和力度
    • 市场挑战
      • 肝转移治疗费用高
    • 市场机会
      • 肝转移治疗技术进展
      • 激活医疗保健领域的研发

第四章肝转移药物全球市场行业分析

  • 波特 5 力模型
    • 供应商的议价能力
    • 买家的议价能力
    • 新进入者的威胁
    • 替代品的威胁
    • 竞争公司之间的敌对关係
  • 波特 5 力模型的未来方法 (2019-2029)
  • 害虫分析
    • 政治
    • 经济的
    • 社交
    • 技术
  • 投资招聘模式
  • 分析师的建议和结论
  • 最佳投资机会
  • 关键成功策略

第 5 章风险评估 COVID-19 影响

  • 评估 COVID-19 对行业的总体影响
  • COVID-19 之前和 COVID-19 之后的市场情景

第 6 章全球肝转移药物市场：按类型分类

  • 市场概况
  • 肝转移药物的全球市场：按类型和性能分类 - 潜力分析
  • 2019-2029 年按类型分列的全球肝转移药物市场估计和预测
  • 肝转移药物市场，细分市场分析
    • 化疗
    • 靶向治疗
    • 免疫疗法

第 7 章。肝转移药物的全球市场：按原发性癌症分类

  • 市场概况
  • 用于治疗肝转移的药物的全球市场：按原发性癌症、按性能）- 潜力分析
  • 2019-2029 年全球原发癌肝转移药物市场预估与预测
  • 肝转移治疗市场，按细分市场分析
    • 结直肠癌
    • 乳腺癌

第 8 章全球肝转移药物市场：按分销渠道

  • 市场概况
  • 肝转移药物的全球市场：按分销渠道进行的性能潜力分析
  • 2019-2029 年肝转移药物的全球市场估计和预测（按分销渠道）
  • 肝转移药物市场，细分市场分析
    • 医院药房
    • 专业药房

第 9 章全球肝转移药物市场：区域分析

  • 肝转移治疗市场，按地区划分的市场概况
  • 北美
    • 美国
      • 按类型估算和预测，2019-2029 年
      • 原发性癌症的估计和预测，2019-2029 年
      • 2019-2029 年各分销渠道的估计和预测
    • 加拿大
  • 欧洲肝转移药物市场概况
    • 英国
    • 德国
    • 法国
    • 西班牙
    • 意大利
    • 其他欧洲
  • 亚太地区肝转移药物市场概况
    • 中国
    • 印度
    • 日本
    • 澳大利亚
    • 韩国
    • 其他亚太地区
  • 拉丁美洲肝转移药物市场概况
    • 巴西
    • 墨西哥
  • 世界其他地方

第 10 章衝突信息

  • 顶级市场策略
  • 公司简介
    • F. Hoffmann-La Roche Ltd.
      • 关键信息
      • 概览
      • 财务（仅当数据可用时）
      • 产品概述
      • 近期趋势
    • AstraZeneca
    • Bayer AG
    • Eli Lilly and Company
    • Ono Pharmaceutical
    • Pfizer, Inc.
    • Bristol-Myers Squibb Company
    • Cadila Pharmaceuticals Ltd.
    • Biocare Medical, LLC
    • Foundation Medicine, Inc.

第 11 章研究过程

  • 研究过程
    • 数据挖掘
    • 分析
    • 市场评估
    • 验证
    • 出版
  • 调查的特点
  • 调查先决条件

Global Liver Metastases Treatment Market is valued at approximately USD 1.2 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 7.2% over the forecast period 2022-2029. Liver Metastases are spread from an original Tumor or cancer to the liver. Liver Metastases do not begin with the Liver, they spread from other affected body parts. Cancers that spread to the liver cause Liver Metastases. Liver Metastases Treatment is the method used to cure Liver Metastases. Some of the common cancers that spread to the liver are breast cancer, colorectal cancer, esophageal cancer, and lung cancer. Increasing cases of breast and colorectal cancer, increasing government support and initiatives in cancer treatment, growing research and development, and rising incidence of target disease are the factors driving the growth of the market.

According to the World Cancer Research Fund, the global number of breast cancer cases was around 12.5% in the year 2020, whereas Lung cancer cases were around 12.2% in the same year. With 1.9 million new cases in 2020, colorectal cancer ranked third among all cancer types and accounted for 10.7% of all cases. Additionally, World Health Organisation unveiled a new global breast cancer initiative framework in February 2023, to achieve the goal of preventing 2.5 million deaths from breast cancer by 2040. The increasing cases of breast and colorectal cancer and increasing government support and initiatives are the major factors driving the growth of the market. Other important components driving market increase are growing research and development and the rising incidence of the target disease. Technological advancements in Liver Metastases Treatment and increasing R&D in healthcare are creating major market opportunities in the forecast period. However, the high cost of Liver Metastases Treatment stifles market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Liver Metastases Treatment Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the market in terms of revenue, owing to the availability of advanced treatment options for cancer, favorable government policies for cancer, and the high prevalence of liver metastases in the country such as the US. For instance, there are around 140,000 liver metastases cases annually in the US. Asia Pacific is expected to grow with the highest CAGR during the forecast period, owing to factors such as increasing healthcare expenditure, easy access to healthcare facilities, and lack of effective screening practices in the region.

Major market players included in this report are:

  • F. Hoffmann - La Roche Ltd.
  • AstraZeneca
  • Bayer AG
  • Eli Lilly and Company
  • Ono Pharmaceutical
  • Pfizer, Inc.
  • Bristol - Myers Squibb Company
  • Cadila Pharmaceuticals Ltd.
  • Biocare Medical, LLC
  • Foundation Medicine, Inc.

Recent Developments in the Market:

  • In March 2020, Nivolumab and ipilimumab were given rapid approval by the Food and Drug Administration to Ono Pharmaceuticals for the treatment of patients with hepatocellular carcinoma (HCC) who had previously been diagnosed with sorafenib.
  • In May 2020, atezolizumab and bevacizumab have been given FDA approval for the treatment of adult patients with unresectable locally advanced or metastatic hepatocellular carcinoma (HCC) who have not had any prior systemic therapy.

Global Liver Metastases Treatment Market Report Scope:

  • Historical Data 2019-2020-2021
  • Base Year for Estimation 2021
  • Forecast period 2022-2029
  • Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
  • Segments Covered Type, Primary Cancer, Distribution Channel, Region
  • Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World
  • Customization Scope Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and Type offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Type:

  • Chemotherapy
  • Targeted Therapy
  • Immunotherapy

By Primary Cancer:

  • Colorectal Cancer
  • Breast Cancer

By Distribution Channel:

  • Hospital Pharmacies
  • Specialty Pharmacies

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • Rest of the World

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
    • 1.2.1. Liver Metastases Treatment Market, by Region, 2019-2029 (USD Billion)
    • 1.2.2. Liver Metastases Treatment Market, by Type, 2019-2029 (USD Billion)
    • 1.2.3. Liver Metastases Treatment Market, by Primary Cancer, 2019-2029 (USD Billion)
    • 1.2.4. Liver Metastases Treatment Market, by Distribution Channel, 2019-2029 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Liver Metastases Treatment Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Liver Metastases Treatment Market Dynamics

  • 3.1. Liver Metastases Treatment Market Impact Analysis (2019-2029)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Increasing cases of breast and colorectal cancer
      • 3.1.1.2. Increasing government support and initiatives in cancer treatment
    • 3.1.2. Market Challenges
      • 3.1.2.1. High Cost of Liver Metastases Treatment
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Technological advancements in Liver Metastases Treatment
      • 3.1.3.2. Increasing R&D in healthcare

Chapter 4. Global Liver Metastases Treatment Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economical
    • 4.3.3. Social
    • 4.3.4. Technological
  • 4.4. Investment Adoption Model
  • 4.5. Analyst Recommendation & Conclusion
  • 4.6. Top investment opportunity
  • 4.7. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact

  • 5.1. Assessment of the overall impact of COVID-19 on the industry
  • 5.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Liver Metastases Treatment Market, by Type

  • 6.1. Market Snapshot
  • 6.2. Global Liver Metastases Treatment Market by Type, Performance - Potential Analysis
  • 6.3. Global Liver Metastases Treatment Market Estimates & Forecasts by Type 2019-2029 (USD Billion)
  • 6.4. Liver Metastases Treatment Market, Sub Segment Analysis
    • 6.4.1. Chemotherapy
    • 6.4.2. Targeted Therapy
    • 6.4.3. Immunotherapy

Chapter 7. Global Liver Metastases Treatment Market, by Primary Cancer

  • 7.1. Market Snapshot
  • 7.2. Global Liver Metastases Treatment Market by Primary Cancer, Performance - Potential Analysis
  • 7.3. Global Liver Metastases Treatment Market Estimates & Forecasts by Primary Cancer 2019-2029 (USD Billion)
  • 7.4. Liver Metastases Treatment Market, Sub Segment Analysis
    • 7.4.1. Colorectal Cancer
    • 7.4.2. Breast Cancer

Chapter 8. Global Liver Metastases Treatment Market, by Distribution Channel

  • 8.1. Market Snapshot
  • 8.2. Global Liver Metastases Treatment Market by Distribution Channel, Performance - Potential Analysis
  • 8.3. Global Liver Metastases Treatment Market Estimates & Forecasts by Distribution Channel 2019-2029 (USD Billion)
  • 8.4. Liver Metastases Treatment Market, Sub Segment Analysis
    • 8.4.1. Hospital Pharmacies
    • 8.4.2. Specialty Pharmacies

Chapter 9. Global Liver Metastases Treatment Market, Regional Analysis

  • 9.1. Liver Metastases Treatment Market, Regional Market Snapshot
  • 9.2. North America Liver Metastases Treatment Market
    • 9.2.1. U.S. Liver Metastases Treatment Market
      • 9.2.1.1. Type breakdown estimates & forecasts, 2019-2029
      • 9.2.1.2. Primary Cancer breakdown estimates & forecasts, 2019-2029
      • 9.2.1.3. Distribution Channel breakdown estimates & forecasts, 2019-2029
    • 9.2.2. Canada Liver Metastases Treatment Market
  • 9.3. Europe Liver Metastases Treatment Market Snapshot
    • 9.3.1. U.K. Liver Metastases Treatment Market
    • 9.3.2. Germany Liver Metastases Treatment Market
    • 9.3.3. France Liver Metastases Treatment Market
    • 9.3.4. Spain Liver Metastases Treatment Market
    • 9.3.5. Italy Liver Metastases Treatment Market
    • 9.3.6. Rest of Europe Liver Metastases Treatment Market
  • 9.4. Asia-Pacific Liver Metastases Treatment Market Snapshot
    • 9.4.1. China Liver Metastases Treatment Market
    • 9.4.2. India Liver Metastases Treatment Market
    • 9.4.3. Japan Liver Metastases Treatment Market
    • 9.4.4. Australia Liver Metastases Treatment Market
    • 9.4.5. South Korea Liver Metastases Treatment Market
    • 9.4.6. Rest of Asia Pacific Liver Metastases Treatment Market
  • 9.5. Latin America Liver Metastases Treatment Market Snapshot
    • 9.5.1. Brazil Liver Metastases Treatment Market
    • 9.5.2. Mexico Liver Metastases Treatment Market
  • 9.6. Rest of The World Liver Metastases Treatment Market

Chapter 10. Competitive Intelligence

  • 10.1. Top Market Strategies
  • 10.2. Company Profiles
    • 10.2.1. F. Hoffmann - La Roche Ltd.
      • 10.2.1.1. Key Information
      • 10.2.1.2. Overview
      • 10.2.1.3. Financial (Subject to Data Availability)
      • 10.2.1.4. Product Summary
      • 10.2.1.5. Recent Developments
    • 10.2.2. AstraZeneca
    • 10.2.3. Bayer AG
    • 10.2.4. Eli Lilly and Company
    • 10.2.5. Ono Pharmaceutical
    • 10.2.6. Pfizer, Inc.
    • 10.2.7. Bristol - Myers Squibb Company
    • 10.2.8. Cadila Pharmaceuticals Ltd.
    • 10.2.9. Biocare Medical, LLC
    • 10.2.10. Foundation Medicine, Inc.

Chapter 11. Research Process

  • 11.1. Research Process
    • 11.1.1. Data Mining
    • 11.1.2. Analysis
    • 11.1.3. Market Estimation
    • 11.1.4. Validation
    • 11.1.5. Publishing
  • 11.2. Research Attributes
  • 11.3. Research Assumption

LIST OF TABLES

  • TABLE 1. Global Liver Metastases Treatment Market, report scope
  • TABLE 2. Global Liver Metastases Treatment Market estimates & forecasts by Region 2019-2029 (USD Billion)
  • TABLE 3. Global Liver Metastases Treatment Market estimates & forecasts by Type 2019-2029 (USD Billion)
  • TABLE 4. Global Liver Metastases Treatment Market estimates & forecasts by Primary Cancer 2019-2029 (USD Billion)
  • TABLE 5. Global Liver Metastases Treatment Market estimates & forecasts by Distribution Channel 2019-2029 (USD Billion)
  • TABLE 6. Global Liver Metastases Treatment Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 7. Global Liver Metastases Treatment Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 8. Global Liver Metastases Treatment Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 9. Global Liver Metastases Treatment Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 10. Global Liver Metastases Treatment Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 11. Global Liver Metastases Treatment Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 12. Global Liver Metastases Treatment Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 13. Global Liver Metastases Treatment Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 14. Global Liver Metastases Treatment Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 15. Global Liver Metastases Treatment Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 16. U.S. Liver Metastases Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 17. U.S. Liver Metastases Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 18. U.S. Liver Metastases Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 19. Canada Liver Metastases Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 20. Canada Liver Metastases Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 21. Canada Liver Metastases Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 22. UK Liver Metastases Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 23. UK Liver Metastases Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 24. UK Liver Metastases Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 25. Germany Liver Metastases Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 26. Germany Liver Metastases Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 27. Germany Liver Metastases Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 28. France Liver Metastases Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 29. France Liver Metastases Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 30. France Liver Metastases Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 31. Italy Liver Metastases Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 32. Italy Liver Metastases Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 33. Italy Liver Metastases Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 34. Spain Liver Metastases Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 35. Spain Liver Metastases Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 36. Spain Liver Metastases Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 37. RoE Liver Metastases Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 38. RoE Liver Metastases Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 39. RoE Liver Metastases Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 40. China Liver Metastases Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 41. China Liver Metastases Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 42. China Liver Metastases Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 43. India Liver Metastases Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 44. India Liver Metastases Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 45. India Liver Metastases Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 46. Japan Liver Metastases Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 47. Japan Liver Metastases Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 48. Japan Liver Metastases Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 49. South Korea Liver Metastases Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 50. South Korea Liver Metastases Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 51. South Korea Liver Metastases Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 52. Australia Liver Metastases Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 53. Australia Liver Metastases Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 54. Australia Liver Metastases Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 55. RoAPAC Liver Metastases Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 56. RoAPAC Liver Metastases Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 57. RoAPAC Liver Metastases Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 58. Brazil Liver Metastases Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 59. Brazil Liver Metastases Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 60. Brazil Liver Metastases Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 61. Mexico Liver Metastases Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 62. Mexico Liver Metastases Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 63. Mexico Liver Metastases Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 64. RoLA Liver Metastases Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 65. RoLA Liver Metastases Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 66. RoLA Liver Metastases Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 67. Row Liver Metastases Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 68. Row Liver Metastases Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 69. Row Liver Metastases Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 70. List of secondary sources, used in the study of global Liver Metastases Treatment Market
  • TABLE 71. List of primary sources, used in the study of global Liver Metastases Treatment Market
  • TABLE 72. Years considered for the study
  • TABLE 73. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

List of figures

  • FIG 1. Global Liver Metastases Treatment Market, research methodology
  • FIG 2. Global Liver Metastases Treatment Market, Market estimation techniques
  • FIG 3. Global Market size estimates & forecast methods
  • FIG 4. Global Liver Metastases Treatment Market, key trends 2021
  • FIG 5. Global Liver Metastases Treatment Market, growth prospects 2022-2029
  • FIG 6. Global Liver Metastases Treatment Market, porters 5 force model
  • FIG 7. Global Liver Metastases Treatment Market, pest analysis
  • FIG 8. Global Liver Metastases Treatment Market, value chain analysis
  • FIG 9. Global Liver Metastases Treatment Market by segment, 2019 & 2029 (USD Billion)
  • FIG 10. Global Liver Metastases Treatment Market by segment, 2019 & 2029 (USD Billion)
  • FIG 11. Global Liver Metastases Treatment Market by segment, 2019 & 2029 (USD Billion)
  • FIG 12. Global Liver Metastases Treatment Market by segment, 2019 & 2029 (USD Billion)
  • FIG 13. Global Liver Metastases Treatment Market by segment, 2019 & 2029 (USD Billion)
  • FIG 14. Global Liver Metastases Treatment Market, regional snapshot 2019 & 2029
  • FIG 15. North America Liver Metastases Treatment Market 2019 & 2029 (USD Billion)
  • FIG 16. Europe Liver Metastases Treatment Market 2019 & 2029 (USD Billion)
  • FIG 17. Asia pacific Liver Metastases Treatment Market 2019 & 2029 (USD Billion)
  • FIG 18. Latin America Liver Metastases Treatment Market 2019 & 2029 (USD Billion)
  • FIG 19. Global Liver Metastases Treatment Market, company Market share analysis (2021)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable